Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Department of Clinical Research Centre, Yanbian University Hospital, Yanji, China.
Pflugers Arch. 2020 Mar;472(3):367-374. doi: 10.1007/s00424-020-02355-8. Epub 2020 Feb 20.
Recent evidence suggests that mitochondrial complex II is an essential mediator of myocardial ischemia-reperfusion injury. The present study aimed to investigate the effects of fatty acid supplementation or high-fat diet (HFD) on cardiac mitochondrial activity. The changes of complex I and complex II activities and mitochondrial oxygen consumption rate (OCR) following hypoxia and re-oxygenation under these conditions were studied. Our results have shown that OCR (mitochondrial activity) was significantly increased with palmitoylcarnitine supplementation in mitochondria-enriched fraction from C57BL/6 mice hearts. Mitochondrial complex I activity was unaffected by palmitoylcarnitine but complex II activity was enhanced. Re-oxygenation following 30-min hypoxia transiently increased OCR but such an effect on OCR was abolished by complex II inhibitor, malonate, but not by complex I inhibitor, rotenone, despite that complex I activity was significantly increased with re-oxygenation following hypoxia in the presence of palmitoylcarnitine. Furthermore, OCR and complex II activity were significantly increased in the mitochondria from high-fat diet mice heart compared with those of normal or low-fat diet mice. Re-oxygenation to mitochondria following 30-min hypoxia increased OCR in all three groups but significantly more in HFD. Malonate abolished re-oxygenation-induced OCR increment in all groups. Our results indicate that complex II activity and OCR are enhanced with palmitoylcarnitine or in HFD mice heart. Although re-oxygenation following hypoxia enhanced complex II and complex I activities, complex II plays an important role in increasing mitochondrial activity, which may be instrumental in myocardial injury following ischemic reperfusion.
最近的证据表明,线粒体复合物 II 是心肌缺血再灌注损伤的重要介质。本研究旨在探讨脂肪酸补充或高脂肪饮食(HFD)对心脏线粒体活性的影响。研究了在这些条件下缺氧和再复氧时复合物 I 和复合物 II 活性以及线粒体耗氧率(OCR)的变化。我们的结果表明,在 C57BL/6 小鼠心脏的线粒体富集部分中,添加棕榈酰肉碱可显著增加 OCR(线粒体活性)。棕榈酰肉碱对线粒体复合物 I 活性没有影响,但对复合物 II 活性有增强作用。缺氧 30 分钟后的再复氧短暂增加了 OCR,但这种对 OCR 的影响被丙二酸盐(复合物 II 抑制剂)而不是鱼藤酮(复合物 I 抑制剂)所消除,尽管在缺氧后再复氧时复合物 I 活性在存在棕榈酰肉碱的情况下显著增加。此外,与正常或低脂饮食的小鼠相比,高脂肪饮食小鼠心脏的线粒体中 OCR 和复合物 II 活性显著增加。再复氧到缺氧 30 分钟后的线粒体可增加所有三组的 OCR,但在 HFD 组中增加更多。丙二酸盐消除了所有三组中再复氧诱导的 OCR 增加。我们的结果表明,复合物 II 活性和 OCR 在棕榈酰肉碱或 HFD 小鼠心脏中增强。尽管缺氧后的再复氧增强了复合物 II 和复合物 I 的活性,但复合物 II 在增加线粒体活性方面起着重要作用,这可能对缺血再灌注后的心肌损伤有帮助。